Partnerships are fundamental to the way in which we run our business. They help to build trust among our key stakeholders and to reach a better understanding of a variety of important issues. Partnerships also pave the way for more successful solutions to problems, concerns and challenges. We partner with others to address societal problems that are integral for our long-term business success, to leverage our assets and expertise to deal with the problem, play a role in mobilising stakeholders and driving concerted action, and finally to measure and learn from results.
Partnerships that Novo Nordisk is part of include:
- As a member of the World Wide Fund for Nature (WWF) Climate Savers initiative, Novo Nordisk is one of 18 companies that have agreed to work to achieve an absolute reduction in the company's CO2 emissions to combat global warming. Climate Savers is the only programme that helps businesses make and achieve voluntary commitments to reduce the impact of their corporate activities on climate change. WWF works with businesses to develop cost-effective energy strategies to demonstrate that increasing efficiency and aggressively reducing greenhouse gas emissions can benefit the environment and the economy in numerous ways.
- For some years, Novo Nordisk has had a partnership agreement with the Danish energy company, DONG Energy. Under the partnership, Novo Nordisk pledges to convert all energy savings realised at its Danish production into the purchase of electricity from a wind farm in the North Sea. With the agreement, Novo Nordisk has devised a cost-neutral way to significantly achieve reductions in CO2 emissions and at the same time helps build the market for renewable energy in Denmark.
Access to health
Novo Nordisk co-operates with governments, healthcare providers, NGOs, universities, healthcare professionals and diabetes associations worldwide to establish data, build evidence and pilot new intervention approaches. The new global access programme builds on the experience gained during the past five years of work through several initiatives. Programmes such as the pioneering World Partnership programme in eight developing countries; the pricing policy focused on offering affordable insulin to the world's 48 least developed countries; and the projects funded by the World Diabetes Foundation have one common denominator: they offer a partnership approach to filling gaps in under-resourced and unsustainable healthcare systems.
For more information about access to health, click here.
WWF Climate Savers initiative
As a member of the World Wide Fund for Nature (WWF) Climate Savers initiative, Novo Nordisk is one of 18 companies that have agreed to work to achieve an absolute reduction in the company's CO2 emissions to combat global warming. Climate Savers is the only programme that helps businesses make and achieve voluntary commitments to reduce the impact of their corporate activities on climate change. WWF works with businesses to develop cost-effective energy strategies to demonstrate that increasing efficiency and aggressively reducing greenhouse gas emissions can benefit the environment and the economy in numerous ways.
For more information about our climate action programme, click here.
Establishing a national stem cell research centre
In March 2010 a new Danish national stem cell research centre, DanStem was established at the University of Copenhagen. The centre will comprise two separate sections:
- A section for basic stem cell biology (BasicStem) and
- A section for strategic translational stem cell research and therapy (TransStem).
BasicStem is supported by a grant of 47 million euro from The Novo Nordisk Foundation and TransStem by a grant of 8,7 million euro from the Danish Council of Strategic Research. TransStem researchers will collaborate with the University hospital, Rigshospitalet, Uppsala University and Novo Nordisk A/S.
For more information about our stem cell research, click here.